Decreased DROSHA expression has been detected in bone marrow stromal and hematopoietic cells from MDS patients, suggesting impaired production of tumor-suppressive miRNAs such as those of the miR-34 family under p53 control [6,7,8]. The gene discussed is DROSHA; the disease is myelodysplastic syndrome.